TEVA losing ground in pharma segment
TEVA, being the major importer of bulk drugs and intermediates from the country, which accounts for about Rs 250 crore per annum. SOL had earlier entered into supply agreements with the Israeli drug company and obtained interest-free advance of $2.5 million against the supplies of sulphamethaxazole in April 1997.

Common problem of chemical industries
One common woe of the chemical industry is the high cost of inputs like power, fuel and water. Water till recently was carelessly used by the industry but with rising cost companies have started carrying out water management systems by monitoring its usage. Some of the new companies today are recycling water as much as possible before discharging it.

Indian foils faces severe liquidity crunch
India Foils' financial troubles are well known. Even in 1996-97, the debt/equity ratio was 2.65:1. In 1997-98, its net loss was Rs 3.88 crore, and in the first quarter of the year the loss was Rs 3.22 crore. Considering the performance, equity dilution was never a possibility.